Globe Newswire
FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)
1. KEY INFORMATION
(a) Full name of discloser:Man Group PLC(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor... (continue reading...)- Generated record quarterly net revenues of $137.4 million, representing year-over-year growth of 28.7%, net income to common shareholders of $17.8 million, and GAAP diluted earnings per share of $0.82
- Delivered record adjusted non-GAAP EBITDA of $37.6 million, and adjusted non-GAAP diluted earnings per share of $1.21
- Rare Disease business delivered Q1 net revenues of $36.9 million, representing year-over-year growth of 126.2%
- Reiterated 2024 guidance of net revenues of... (continue reading...)
FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)
1. KEY INFORMATION
(a) Full name of discloser:Man Group PLC(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor... (continue reading...)FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)
1. KEY INFORMATION
(a) Full name of discloser:Man Group PLC(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor... (continue reading...)FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)
1. KEY INFORMATION
(a) Full name of discloser:Man Group PLC(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor... (continue reading...)More Globe Newswire
View Older Stories-
Man Group PLC : Form 8.3 - Tyman plc
-
CENTOGENE Biodatabank Grows to Incorporate Disease Insights From Over 850,000 Diverse Patients
-
FTC Solar Announces First Quarter 2024 Financial Results
-
Chart Industries to Participate in Investor Events
-
NOTICE TO THE ANNUAL GENERAL MEETING
-
Dimensional Fund Advisors Ltd. : Form 8.3 - VIRGIN MONEY UK PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - SPIRENT COMMUNICATIONS PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - Redrow plc - Ordinary Shares
-
Costamare Inc. Reports Results for the First Quarter Ended March 31, 2024
-
Dimensional Fund Advisors Ltd. : Form 8.3 - INTERNATIONAL PAPER CO - Ordinary Shares
-
LKQ Corporation Executes Agreement to Sell Elit Polska in Poland to MEKO AB
-
Mondee Reports First Quarter 2024 Results
-
Dimensional Fund Advisors Ltd. : Form 8.3 - INTERNATIONAL DISTRIBUTIONS - Ordinary Shares
-
KE Holdings Inc. to Report First Quarter 2024 Financial Results on May 23, 2024 Eastern Time
-
Media advisory: NS Police Officers will Receive Constable Heidi Stevenson’s Watch Award on May 13
-
Defiance Launches USOY, The First Oil Enhanced Options Income ETF.
-
Tessera Therapeutics Presents New Preclinical Data Highlighting Advancements Across Its Portfolio Programs and Platforms at the American Society of Gene and Cell Therapy 27th Annual Meeting
-
Agora, Inc. to Report First Quarter 2024 Financial Results on May 22, 2024
-
Bilibili Inc. to Report First Quarter 2024 Financial Results on Thursday, May 23, 2024
-
Digihost to Announce Q1 Results on May 14th
-
Editas Medicine Preclinical Data Highlights Advancement of in vivo Gene Editing Medicine Technologies at the American Society of Gene and Cell Therapy Annual Meeting
-
AirSculpt Technologies Reports for First Quarter Earnings
-
Tome Biosciences Presented Data on its Programmable Genomic Integration Technologies at ASGCT
-
Enovis to Participate in Upcoming Investor Conferences
-
Net Asset Value(s)
-
IOTSWC unveils the latest disruptive technologies for industrial transformation
-
Dimensional Fund Advisors Ltd. : Form 8.3 - DS SMITH PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - BARRATT DEVELOPMENTS PLC - Ordinary Shares
-
Form 8.3 - AXA INVESTMENT MANAGERS: Spirent Communications plc
-
HSBC Bank Plc - Form 8.5 (EPT/RI) - Wood Group (John) plc
-
BitFuFu Inc. to Report First Quarter 2024 Unaudited Financial Results on May 20, 2024
-
Vaisala Corporation: Disclosure in compliance with Chapter 9, Section 10 of the Finnish Securities Markets Act (May 10, 2024)
-
RESULT OF RIKSBANK AUCTIONS GOVERNMENT BONDS
-
General Assembly minutes
-
Enefit Green production data – April 2024
-
Form 8.5 (EPT/RI) - Mattioli Woods
-
Flash News: OKX Ventures Announces Investment in Blade of God X, an Action RPG Developed by Void Labs
-
Scandinavian Tobacco Group A/S - Reduction of share capital
-
Form 8.5 (EPT/RI) - musicMagpie Plc
-
Form 8.5 (EPT/RI) - Touchstone Exploration Inc.
-
Form 8.5 (EPT/RI) - Trinity Exploration & Production Plc
-
HSBC Continental Europe: Post Stabilisation Notice
-
Calian® Completes Acquisition of Mabway, Expanding Military Training and Simulation Solutions Globally
-
HSBC Continental Europe: Post Stabilisation Notice
-
The sales of VILVI GROUP April 2024
-
Procedure for the payment of AB Amber Grid dividends for 2023
-
Ex-Dividend Date
-
Banco Comercial Português, S.A. informs about Bank Millennium (Poland) results in Q1 2024
-
Form 8.5 (EPT/RI) - Abrdn European Logistics Income Plc
-
Grieg Seafood ASA: Presentation of first quarter 2024 results